Testing Platform for Pharmacological Compounds that Target Glutamate Transmission
The Molecular Basis for Psychopathology Lab, headed by Dr. Inna Gaisler-Salomon in the University of Haifa’s Department of Psychology, uses animal models and a combination of genetic, molecular and behavior tools to address specific questions related to the etiology, symptomatology and treatment of schizophrenia and stress-related behavior.
Animal Models and Targets for Pharmacological Testing
Backed by its research upholding glutamate transmission as a novel treatment target for symptoms of schizophrenia, the Gaisler-Salomon Lab is able to provide a novel animal model testing platform for pharmacological compounds that target glutamate transmission. A unique battery of behavioral assays (some of which are commonly used and others developed in-house) is capable of detecting deficits in central aspects of schizophrenia-related symptomatology, such as deficits in salience attribution and attentional set shifting.
Related Pages
Inna Gaisler- Salomon, Dr. - Researcher page
